Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.

Infection with Helicobacter pylori is a major cause of gastric cancer (GC). The association likely has been underestimated in the past due to disease-related clearance of the infection. On the other hand, only a minority of the infected individuals develop GC, and better risk stratification is therefore highly desirable. We aimed to assess the association of GC with antibodies to 15 individual H. pylori proteins, determined by novel multiplex serology, to identify potentially relevant risk markers. This analysis was based on 123 GC cases aged 50 to 74 years and 492 age-matched and sex-matched controls from Saarland, Germany. Eight of the antibodies were significantly associated with noncardia GC and seven of them were significantly related to GC at any site. More pronounced associations were observed for noncardia GC; adjusted odds ratios (95% confidence intervals) ranged from 1.60 (1.01-2.54) for HyuA to 5.63 (3.20-9.91) for cytotoxin-associated antigen A (CagA). A dose-response relationship was found between the number of seropositivities and GC (P < 0.001). The seropositivities of CagA and GroEL were found to be independent predictors of GC, which were strongly related to GC risk in a dose-response manner (P < 0.001). In conclusion, GroEL was identified as a new independent risk marker that may contribute to enhanced quantification of H. pylori-related GC risk.

[1]  H. Brenner,et al.  Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. , 2009, Cancer research.

[2]  J. Barrett,et al.  Immunoblotting using multiple antigens is essential to demonstrate the true risk of Helicobacter pylori infection for gastric cancer , 2008, Alimentary pharmacology & therapeutics.

[3]  H. Brenner,et al.  Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer. , 2008, The Journal of urology.

[4]  H. Rautelin,et al.  Evaluation of a Commercial Immunoblot, Helicoblot 2.1, for Diagnosis of Helicobacter pylori Infection , 2008, Clinical and Vaccine Immunology.

[5]  Y. Yamaoka,et al.  Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. , 2008, Internal medicine.

[6]  M. Colozza,et al.  CagA and VacA Helicobacter pylori antibodies in gastric cancer. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[7]  H. Brenner,et al.  Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff‐value , 2007, International journal of cancer.

[8]  P. Malfertheiner,et al.  Helicobacter and Gastric Malignancies , 2007, Helicobacter.

[9]  P. Correa,et al.  Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.

[10]  R. Hunt,et al.  The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis , 2007, The American Journal of Gastroenterology.

[11]  E. Lahner,et al.  CagA and VacA are Immunoblot Markers of Past Helicobacter pylori Infection in Atrophic Body Gastritis , 2007, Helicobacter.

[12]  Ding-Shinn Chen,et al.  Comparative Immunoproteomics of Identification and Characterization of Virulence Factors from Helicobacter pylori Related to Gastric Cancer * S , 2006, Molecular & Cellular Proteomics.

[13]  G. Bergonzelli,et al.  GroEL of Lactobacillus johnsonii La1 (NCC 533) Is Cell Surface Associated: Potential Role in Interactions with the Host and the Gastric Pathogen Helicobacter pylori , 2006, Infection and Immunity.

[14]  D. Forman,et al.  Gastric cancer: global pattern of the disease and an overview of environmental risk factors. , 2006, Best practice & research. Clinical gastroenterology.

[15]  D. Graham,et al.  Helicobacter pylori virulence factors: facts and fantasies , 2005, Current opinion in gastroenterology.

[16]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[17]  H. Brenner,et al.  Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? , 2004, American journal of epidemiology.

[18]  T. Meyer,et al.  Identification of candidate antigens for serologic detection of Helicobacter pylori‐infected patients with gastric carcinoma , 2004, International journal of cancer.

[19]  R. Hunt,et al.  Meta-analysis of the relationship between cagA seropositivity and gastric cancer. , 2003, Gastroenterology.

[20]  P. Hohenberger,et al.  Helicobacter pylori virulence factors—one part of a big picture , 2003, The Lancet.

[21]  J. Virtamo,et al.  Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[22]  M. Hatakeyama.  Helicobacter pylori CagA--a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. , 2003, Microbes and infection.

[23]  Toni Aebischer,et al.  Immunoproteomics of Helicobacter pylori infection and relation to gastric disease , 2002, Proteomics.

[24]  J. d'Alayer,et al.  Novel Antigens of Helicobacter pylori Correspond to Ulcer-Related Antibody Pattern of Sera from Infected Patients , 2002, Journal of Clinical Microbiology.

[25]  L. Hansson,et al.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.

[26]  D. Evans,et al.  Helicobacter pylori CagA: Analysis of Sequence Diversity in Relation to Phosphorylation Motifs and Implications for the Role of CagA as a Virulence Factor , 2001, Helicobacter.

[27]  W. Goebel,et al.  Identification of Immunodominant Antigens fromHelicobacter pylori and Evaluation of Their Reactivities with Sera from Patients with Different Gastroduodenal Pathologies , 2000, Infection and Immunity.

[28]  D. Graham,et al.  Disease‐specific Helicobacter pylori Virulence Factors: The Unfulfilled Promise , 2000, Helicobacter.

[29]  J. Byles,et al.  Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis , 1999, American Journal of Gastroenterology.

[30]  R. Hunt,et al.  Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. , 1998, Gastroenterology.

[31]  A. Labigne,et al.  Evidence for Specific Secretion Rather than Autolysis in the Release of Some Helicobacter pyloriProteins , 1998, Infection and Immunity.

[32]  I. Kansau,et al.  Heat shock proteins of Helicobacter pylori. , 1996, Alimentary pharmacology & therapeutics.

[33]  N. Høiby,et al.  Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori , 1995, Clinical and diagnostic laboratory immunology.

[34]  A. Labigne,et al.  Helicobacter pylori hspA‐hspB heat‐shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity , 1994, Molecular microbiology.

[35]  R. Rappuoli,et al.  The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases , 1993, Molecular microbiology.

[36]  M. Blaser,et al.  Identification and purification of a cpn60 heat shock protein homolog from Helicobacter pylori , 1992, Infection and immunity.

[37]  W. Karnes,et al.  Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. , 1991, Gastroenterology.

[38]  S. Tannenbaum,et al.  A MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1975, The Lancet.